Juno Therapeutics (JUNO) IPO Opens Up 63%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- BioNTech ends colorectal cancer mRNA therapy trial early
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Needham sees mature node semiconductor strength in latest tracker
Juno Therapeutics (JUNO) IPO Continues Higher, Crosses Above $40
December 22, 2014 10:39 AM ESTLast Friday's IPO for Juno Therapeutics (NASDAQ: JUNO) is continuing hither. After jumping on its debut, shares are up another 14.7% today to $40.04. The IPO priced at $24 and gained 46% on Friday.
... MoreNASDAQ Sets Initial Juno Therapeutics (JUNO) IPO Open Time to 10:25AM ET
December 19, 2014 8:13 AM ESTNASDAQ set the quotation release on the Juno Therapeutics, Inc. (NASDAQ: JUNO) IPO to 10:10 ET and trading at approximately 10:25 ET. The opening trade time is subject to change.
... MoreJuno Therapeutics (JUNO) Prices Upsized Offering at $24, Above Expected Range
December 19, 2014 7:01 AM ESTJuno Therapeutics (NASDAQ: JUNO) priced its initial public offering of 11,022,917 shares of common stock at a price to the public of $24 per share, above the expected $21-$23 range which was recently raised from $15-$18. The number of shares offered was raised from 9,250,000 shares. Juno... More
